Lp-PLA2 et sPLA2 - Biomarqueurs cardiovasculaires
Med Sci (Paris), 30 5 (2014) 526-531
Published online: 2014-06-13
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Antifungal therapy: Novel drug delivery strategies driven by new targets
Shuang Wu, Ruiqi Song, Tongbao Liu and Chong LiAdvanced Drug Delivery Reviews 199 114967 (2023)
https://doi.org/10.1016/j.addr.2023.114967
Strategies of Drug Delivery for Deep Fungal Infection: A Review
Zhongyi Ma, Xiaoyou Wang and Chong LiPharmaceutical Nanotechnology 8 (5) 372 (2020)
https://doi.org/10.2174/2211738508666200910101923
https://doi.org/10.1002/9781118829875.refs
Measuring lipoprotein‐associated phospholipase A2 activity in China: Protocol comparison and recalibration
Danchen Wang, Xiuzhi Guo, Li'an Hou, Xinqi Cheng, Tingting You, Honglei Li, Liangyu Xia, Yicong Yin, Songlin Yu and Ling QiuJournal of Clinical Laboratory Analysis 33 (1) (2019)
https://doi.org/10.1002/jcla.22628
Prospection of Effects of Guava Leaves Infusion: Antigenotoxic Action and Enzymatic Inhibition
Pedro H S Cesar, Marcus V C Trento, Daniela A Oliveira, Anderson A Simão, Larissa F A Vieira and Silvana MarcussiNatural Product Communications 12 (6) (2017)
https://doi.org/10.1177/1934578X1701200631
Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
Juan Zhang, Dong-Ling Xu, Xiao-Bo Liu, et al.Yonsei Medical Journal 57 (2) 321 (2016)
https://doi.org/10.3349/ymj.2016.57.2.321
La Lp-PLA2, marqueur d’inflammation vasculaire et de vulnérabilité de la plaque d’athérosclérose
D. Bonnefont-RousselotAnnales Pharmaceutiques Françaises 74 (3) 190 (2016)
https://doi.org/10.1016/j.pharma.2015.09.002
Nouveaux rôles physiopathologiques pour le récepteur PLA2R1 dans le cancer et la glomérulonéphrite extramembraneuse
Christophe A. Girard, Barbara Seitz-Polski, Guillaume Dolla, et al.médecine/sciences 30 (5) 519 (2014)
https://doi.org/10.1051/medsci/20143005014